Clinical characteristics and prognostic value of pre ‐retreatment plasma epstein‐barr virus DNA in locoregional recurrent nasopharyngeal carcinoma

ConclusionsThe positive rate of pre ‐retreatment plasma EBV DNA in lrNPC is lower than primary NPC. The prognosis of EBV DNA negative group is better than positive group. For locally early‐stage lrNPC, regardless of EBV DNA status, radiotherapy and surgery are available options and both can achieve better long‐term survival.

Source: Cancer Medicine - July 2, 2019 Category: Cancer & Oncology Authors: Ming ‐Zhu Liu, Shuo‐Gui Fang, Wei Huang, Han‐Yu Wang, Yun‐Ming Tian, Run‐Da Huang, Zhuang Sun, Chong Zhao, Tai‐Xiang Lu, Ying Huang, Fei Han Tags: ORIGINAL RESEARCH Source Type: research